Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Imvamune: Phase II data

In a placebo-controlled, German, Phase II trial in 745 volunteers, Imvamune met

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE